After two IPOs launched on Monday, five deals are on the calendar and scheduled to price this week.<\/p>\n
<\/p>\n
The two new IPOs to launch on Monday were Inventiva (IVA) & Poseida Therapeutics (PSTX). They join BlueCity Holdings (BLCT), Quhuo Limited (QH) and Nkarta Inc (NKTX) as the deals for the upcoming week.<\/p>\n
Company: Inventiva S.A.
\nSymbol: IVA
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, mucopolysaccharidoses, or MPS, and other diseases with significant unmet medical need. Their ordinary shares are listed on Euronext Paris under the symbol “IVA.”
\nShares: 7.478 million ADSs
\nPrice Range: $13.68-$13.68
\nMarket Cap: $522m-$522m
\nTrade Date: Friday, 6\/10
\nUnderwriter(s): Jefferies, Stifel, Guggenheim Securities
\nCo-Manager: H.C. Wainwright, Roth Capital Partners, KBC Securities
\nTerms Added; 7-6-20<\/p>\n
Company: Poseida Therapeutics, Inc.
\nSymbol: PSTX
\nDescription: They are a clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need.
\nShares: 10 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $809m-$925m
\nTrade Date: Friday, 7\/10
\nUnderwriter(s): BofA Securities, Piper Sandler, William Blair
\nTerms Added: 7-6-20<\/p>\n
Company: Nkarta, Inc.
\nSymbol: NKTX
\nDescription: They are a biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer, or NK, cell therapies to treat cancer.
\nShares: 10 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $370m-$423m
\nTrade Date: Friday, 7\/10
\nUnderwriter(s): Cowen, Evercore, Stifel, Mizuho
\nTerms Added: 7-2-20<\/p>\n
Company: Quhuo Limited
\nSymbol: QH
\nDescription: They were the largest workforce operational solution platform in China as measured by the number of average monthly active workers in 2019, according to the F&S report. They provide tech-enabled, end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with significant e-commerce exposure, including food delivery, ride-hailing, housekeeping and bike-sharing.
\nShares: 2.7 million ADSs
\nPrice Range: $9.00-$11.00
\nMarket Cap: $461m-$564m
\nTrade Date: Week of July 6
\nUnderwriter(s): Roth Capital Partners, Valuable Capital Limited
\nCo-Manager: Tiger Brokers
\nTerms Added: 6-30-20<\/p>\n
Company: BlueCity Holdings Limited
\nSymbol: BLCT
\nDescription: They are the World\u2019s leading LGBTQ platform.
\nShares: 5.3 million ADSs
\nPrice Range: $15.00-$17.00
\nMarket Cap: $534m-$605m
\nTrade Date: Wednesday, July 8
\nUnderwriter(s):AMTD, Loop Capital Markets, Tiger Brokers, Prime Number Capital, R.F. Lafferty
\nTerms Added: 7-1-20<\/p>\n